KRISTIN HARRIS: Open Payments
NPI 1992053383 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 27 payments from 6 companies in 2025. Trend: 2023 $17 · 2024 $258 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $240 |
| PFIZER INC. | 3 | $60 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
Products named: VRAYLAR, PAXLOVID, CAPLYTA, JARDIANCE, BREZTRI, MOUNJARO.
Industry payments across LA — which companies pay providers there.
